{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:21:17Z","timestamp":1793334077182,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.phymed.2026.158282","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:18:03Z","timestamp":1778757483000},"page":"158282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["5-O-Methylembelin disrupts the ACO1-TPI1 interaction to promote ferroptosis in clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"157","author":[{"given":"Hong","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5055-3637","authenticated-orcid":false,"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158282_bib0001","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.2147\/CMAR.S264856","article-title":"Prognostic role of prothrombin time activity, prothrombin time, albumin\/globulin ratio, platelets, sex, and fibrinogen in predicting recurrence-free survival time of renal cancer","volume":"Volume 12","author":"Bian","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"3","key":"10.1016\/j.phymed.2026.158282_bib0002","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4103\/1673-5374.380889","article-title":"Iron regulatory protein 1: the deadly switch of ferroptosis","volume":"19","author":"B\u00f3rquez","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.phymed.2026.158282_bib0003","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2020.12.021","article-title":"Dynamic 3D proteomes reveal protein functional alterations at high resolution in situ","volume":"184","author":"Cappelletti","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phymed.2026.158282_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acs.jproteome.5c00565","article-title":"Limited proteolysis-coupled mass spectrometry (LiP-MS): a cutting-edge tool for de novo drug target discovery","volume":"25","author":"Chen","year":"2026","journal-title":"J. Proteome Res."},{"issue":"9","key":"10.1016\/j.phymed.2026.158282_bib0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/ph15091131","article-title":"Embelin and its derivatives: design, synthesis, and potential delivery systems for cancer therapy","volume":"15","author":"Danquah","year":"2022","journal-title":"Pharmaceuticals]"},{"issue":"1","key":"10.1016\/j.phymed.2026.158282_bib0006","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12943-025-02457-w","article-title":"Lipid reprogramming and ferroptosis crosstalk in clear cell renal cell carcinoma: metabolic vulnerabilities and therapeutic targeting","volume":"24","author":"Deng","year":"2025","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.phymed.2026.158282_bib0007","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.phymed.2026.158282_bib0008","first-page":"2270","article-title":"Embelin inhibits constitutive and inducible STAT3 activation in human cancer cells","volume":"10","author":"Heo","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phymed.2026.158282_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.phymed.2026.158282_bib0010","first-page":"1311","article-title":"Embelin: a multifaceted anticancer agent with translational potential in targeting tumor progression and metastasis","volume":"22","author":"Kamath","year":"2023","journal-title":"EXCLI J."},{"issue":"3","key":"10.1016\/j.phymed.2026.158282_bib0011","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/molecules23030621","article-title":"The application of embelin for cancer prevention and therapy","volume":"23","author":"Ko","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.phymed.2026.158282_bib0012","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2017.12.006","article-title":"A map of protein-metabolite interactions reveals principles of chemical communication","volume":"172","author":"Piazza","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phymed.2026.158282_bib0013","first-page":"2417","article-title":"Embelin induces apoptosis and inhibits invasion via modulation of the PI3K\/AKT signaling pathway in cancer cells","volume":"39","author":"Qian","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phymed.2026.158282_bib0014","first-page":"1234","article-title":"Target deconvolution by limited proteolysis coupled to mass spectrometry: proteome-wide structural target engagement profiling","volume":"18","author":"Reber","year":"2023","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.phymed.2026.158282_bib0015","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/biomedicines13051225","article-title":"Inhibition of TPI1 sensitizes cisplatin resistant oral cancer to ferroptosis","volume":"13","author":"Wang","year":"2025","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.phymed.2026.158282_bib0016","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrneph.2017.59","article-title":"Metabolic reprogramming in clear cell renal cell carcinoma","volume":"13","author":"Wettersten","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.phymed.2026.158282_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218244","article-title":"Amino acid metabolic reprogramming in clear cell renal cell carcinoma: pathogenic mechanisms and therapeutic targeting","volume":"640","author":"Xie","year":"2026","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.phymed.2026.158282_bib0018","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/antiox12091739","article-title":"NRF2, a superstar of ferroptosis","volume":"12","author":"Yan","year":"2023","journal-title":"Antioxidants"},{"issue":"1\u20132","key":"10.1016\/j.phymed.2026.158282_bib0019","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.phymed.2026.158282_bib0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158282_bib0021","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3892\/ol.2021.12918","article-title":"Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma","volume":"22","author":"Yao","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phymed.2026.158282_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2025.1752384","article-title":"Metabolic reprogramming in clear cell renal cell carcinoma: core pathways and targeted therapeutic strategies","volume":"16","author":"Zhan","year":"2026","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.phymed.2026.158282_bib0023","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s12672-025-02401-w","article-title":"Metabolic reprogramming and immune microenvironment profiling in clear cell renal cell carcinoma: implications for prognosis, targeted therapy, and drug resistance","volume":"16","author":"Zheng","year":"2025","journal-title":"Discov. Oncol."},{"issue":"24","key":"10.1016\/j.phymed.2026.158282_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413413","article-title":"Tumor metabolic reprogramming and ferroptosis: the impact of glucose, protein, and lipid metabolism","volume":"25","author":"Zhu","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326005167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326005167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:03:49Z","timestamp":1781103829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326005167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":24,"alternative-id":["S0944711326005167"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158282","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-O-Methylembelin disrupts the ACO1-TPI1 interaction to promote ferroptosis in clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"158282"}}